EditorialAnticoagulation Therapy for Patients With New-Onset Postoperative Atrial Fibrillation After Noncardiac Surgery: Must Do, May Do, or Don’t Do?
Section snippets
Funding Sources
The authors have no funding sources to declare.
Disclosures
The authors have no conflicts of interest to disclose.
References (17)
- et al.
2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation
Can J Cardiol
(2018) - et al.
Risk of thromboembolism associated with atrial fibrillation following noncardiac surgery
J Am Coll Cardiol
(2018) - et al.
Perioperative atrial fibrillation in noncardiac surgeries for malignancies and one-year recurrence
Can J Cardiol
(2019) - et al.
Anticoagulant use and the risk of thromboembolism and bleeding in postoperative atrial fibrillation after noncardiac surgery
Can J Cardiol
(2021) - et al.
Bleeding risk in “real world” patients with atrial fibrillation: comparison of two established bleeding prediction schemes in a nationwide cohort
J Thromb Haemost
(2011) - et al.
Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants
J Thromb Haemost JTH
(2018) - et al.
CHADS2 score and risk of new-onset atrial fibrillation: a nationwide cohort study in Taiwan
Int J Cardiol
(2013) - et al.
Major adverse cardiovascular events associated with postoperative atrial fibrillation after noncardiac surgery: a systematic review and meta-analysis
Circ Arrhythm Electrophysiol
(2020)
There are more references available in the full text version of this article.
Cited by (0)
See article by Elharram et al., pages 391–399 of this issue.
See page 361 for disclosure information.
© 2020 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.